Evidence map›Paper›PMID 31892524›Full record

ArticleMolecular & cellular proteomics : MCP2020

The Challenge of Classifying Metastatic Cell Properties by Molecular Profiling Exemplified with Cutaneous Melanoma Cells and Their Cerebral Metastasis from Patient Derived Mouse Xenografts.

Benjamin Neuditschko, Lukas Janker, Laura Niederstaetter, Julia Brunmair, Katharina Krivanek, Sivan Izraely, Orit Sagi-Assif, Tsipi Meshel, Bernhard K Keppler, Giorgia Del Favero and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cancer microenvironment and genomics: evolution in process.Clinical & experimental metastasis · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Benjamin NeuditschkoDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna; Department of Inorganic Chemistry, Faculty of Chemistry, University of Vienna.
Lukas JankerDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna.
Laura NiederstaetterDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna.
Julia BrunmairDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna.
Katharina KrivanekDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna; Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna.
Sivan IzraelyDepartment of Cell Research and Immunology, The George S. Wise Faculty of Life Sciences, Tel Aviv University.
Orit Sagi-AssifDepartment of Cell Research and Immunology, The George S. Wise Faculty of Life Sciences, Tel Aviv University.
Tsipi MeshelDepartment of Cell Research and Immunology, The George S. Wise Faculty of Life Sciences, Tel Aviv University.
Bernhard K KepplerDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Vienna.
Giorgia Del FaveroDepartment of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna; Core Facility Multimodal Imaging, Faculty of Chemistry, University of Vienna.
Isaac P WitzDepartment of Cell Research and Immunology, The George S. Wise Faculty of Life Sciences, Tel Aviv University.
Christopher GernerDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna; Joint Metabolome Facility, Faculty of Chemistry, University of Vienna. Electronic address: christopher.gerner@univie.ac.at.
University of Vienna · ATTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prediction of metastatic properties from molecular analyses still poses a major challenge. Here we aimed at the classification of metastasis-related cell properties by proteome profiling making use of cutaneous and brain-metastasizing variants from single melanomas sharing the same genetic ancestry. Previous experiments demonstrated that cultured cells derived from these xenografted variants maintain a stable phenotype associated with a differential metastatic behavior: The brain metastasizing variants produce more spontaneous micro-metastases than the corresponding cutaneous variants. Four corresponding pairs of cutaneous and metastatic cells were obtained from four individual patients, resulting in eight cell-lines presently investigated. Label free proteome profiling revealed significant differences between corresponding pairs of cutaneous and cerebellar metastases from the same patient. Indeed, each brain metastasizing variant expressed several apparently metastasis-associated proteomic alterations as compared with the corresponding cutaneous variant. Among the differentially expressed proteins we identified cell adhesion molecules, immune regulators, epithelial to mesenchymal transition markers, stem cell markers, redox regulators and cytokines. Similar results were observed regarding eicosanoids, considered relevant for metastasis, such as PGE2 and 12-HETE. Multiparametric morphological analysis of cells also revealed no characteristic alterations associated with the cutaneous and brain metastasis variants. However, no correct classification regarding metastatic potential was yet possible with the present data. We thus concluded that molecular profiling is able to classify cells according to known functional categories but is not yet able to predict relevant cell properties emerging from networks consisting of many interconnected molecules. The presently observed broad diversity of molecular patterns, irrespective of restricting to one tumor type and two main classes of metastasis, highlights the important need to develop meta-analysis strategies to predict cell properties from molecular profiling data. Such base knowledge will greatly support future individualized precision medicine approaches.

Indexed as

AnimalsBiomarkers, TumorBrain NeoplasmsCell Line, TumorCytoplasmHeterograftsHumansMaleMelanomaMice, NudeProteomeProteomicsSkin NeoplasmsBiomarkers, TumorProteomebrain metastasiseicosanoidsMelanomametastasismouse modelsomicstumor microenvironmentxenograft model

Identifiers

PMID31892524
PMCPMC7050108
OpenAlexW2997737439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.